Developer docs
API playgroundTry for free, no card

Search company profiles

Alora

Full company profile

uuid0005vyc

Namestring
Alora
Legal namestring
Alora
Websiteurl
alora.world
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Alora is an agricultural biotechnology company developing multiplex gene-edited crop traits that redirect plant energy from stress defense mechanisms to yield production. Its technology targets plant control systems rather than single genes, producing non-GMO edits that have demonstrated in rice a 1.5x yield increase under optimal greenhouse conditions, a 2-4x yield increase under extreme heat stress, and 100% survival under severe salinity, with 2025 UK open-field trials confirming greenhouse performance translates to real-world conditions. The company's primary operations are at Norwich Research Park in the United Kingdom, with the founding leadership team spanning genetics, plant biology, crop science, agronomy, and commercial ag-biotech experience (Adam Helms CEO, Luke Young CTO, Rory Hornby COO).

Alora operates as a B2B licensor of gene-edited crop traits to seed companies, which would integrate the traits into their commercial seed product lines for distribution to farmers. The company is pre-commercial and is currently focused on validating its traits across multiple crops and genetic backgrounds to support future seed-company commercial partnerships, with multi-location field trials planned for 2026. Marketing and lead generation run through a direct outreach model anchored by the company website's contact form (with categories for investors, seed companies, and general inquiries) and a LinkedIn presence.

The company has raised funding across multiple rounds beginning in 2019 with SOSV (IndieBio), followed by 2020 rounds with Next Humanity Ventures, a 2022 round of $1.4 million led with Mistletoe and Toyota Ventures, and a March 2026 round led by the Neglected Climate Opportunities Fund (Grantham Environmental Trust) with Toyota Ventures participation. Use of the most recent capital is to expand operations and advance ongoing trait development, consistent with a transition from research validation to commercial readiness.

Short descriptiontext

Alora is an agricultural biotechnology company developing non-GMO multiplex gene-edited crop traits that redirect plant energy from stress defense to yield, licensing them B2B to seed companies with rice as the first validated crop.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
gene-edited crop traits, agricultural biotechnology, climate-resilient crops, plant gene editing, crop yield improvement
Industry3 codes
1Gene Editing Trait Development (CRISPR/TALEN/ZFN)
CodeAFABALABPrimaryYes
2Seed Trait Licensing & IP Management (Licensing, freedom-to-operate)
CodeAFABALAJPrimaryNo
3Biotechnology & Gene-Edited Trait Development
CodeAFAGAIAGPrimaryNo
SIC code1 code
  • Agricultural Services700
Product category
Agricultural Biotechnology
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Trait Licensing to Seed Companies
TypeLicensing Royalties
Description

ALORA licenses its gene-edited crop traits to seed companies. The company validates traits across multiple crops and genetic backgrounds to secure future commercial partnerships, generating revenue through trait licensing agreements.

prnewswire.com
2Seed Company Partnerships
TypeLicensing Royalties
Description

The company is pursuing partnerships with seed companies to commercialize its gene-edited traits, indicating a B2B model where seed companies integrate ALORA's traits into their commercial seed products.

alora.world
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Alora develops gene-edited crop traits using multiplex gene editing that targets plant control systems rather than single genes, redirecting plant energy from stress defense mechanisms to yield production. The company licenses these non-GMO traits to seed companies, with demonstrated performance in rice including 1.5x yield increase under optimal conditions, 2-4x yield under extreme heat stress, and 100% survival under severe salinity stress.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Up to 1.5x yield increase under optimal conditions in rice
+3 more records
Product overview1 text field

Alora is an agricultural biotechnology company that develops a unified portfolio of gene-edited crop traits designed to improve how plants use energy, increasing yields under climate stress. The product suite includes Yield Enhancement Traits (up to 1.5× yield increase under optimal conditions), Heat Stress Yield Traits (2–4× yield under extreme heat), and Salinity Tolerance Traits (100% survival under severe salinity). All products are non-GMO and validated through controlled environment research and field trials, with primary operations at Norwich Research Park in the United Kingdom.

Product and service1 record
1Gene-Edited Crop Traits
CategoryAgricultural Biotechnology
Description

A portfolio of non-GMO gene-edited crop traits that redirect plant energy from stress defense to yield, designed for licensing to seed companies for integration into commercial seed products. Validated in rice with potential for application across multiple crops.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Syngenta is one of the world's largest ag-input companies with extensive seed and trait operations across major crops. Broad incumbent competing in the same downstream seed-licensing ecosystem.

TypeEmerging player
Description

Elo Life Systems develops molecular-farming and crop-improvement traits, including yield and stress traits, using genomics and editing tools. Comparable as an emerging trait-licensing platform targeting food and agriculture customers.

TypeBroad incumbent
Description

Corteva is a global seed and crop protection company with a large proprietary trait pipeline including gene-edited traits. A broad incumbent that competes with ALORA for seed-company partnerships and licensing opportunities.

TypeDirect peer
Description

Pairwise applies CRISPR-based gene editing to develop improved crop varieties, initially focused on corn, soybean, wheat, and produce. It competes directly with ALORA for seed-company licensing partnerships and uses the same non-GMO gene-editing regulatory positioning.

TypeBroad incumbent
Description

Bayer's Crop Science division operates the world's largest seed and trait platform, including its own gene-editing initiatives. Represents the dominant incumbent against which any seed-trait platform must compete.

TypeEmerging player
Description

Benson Hill combines genomics, breeding, and AI to develop improved crop varieties for food and feed. Comparable in genomics-driven trait development and B2B seed/food value chain GTM.

TypeEmerging player
Description

Yield10 is a small public ag-biotech developing gene-edited yield and stress traits in major row crops. Comparable in trait licensing model and focus on yield improvement, though at a more advanced public-stage profile.

TypeDirect peer
Description

Tropic Biosciences develops gene-edited traits for tropical crops (banana, coffee, rice) using CRISPR. Direct overlap with ALORA on gene-edited rice traits and on the seed-company licensing GTM.

TypeDirect peer
Description

Inari uses multiplex gene editing and AI to develop performance and sustainability traits in major row crops. It is the closest direct competitor to ALORA in system-level seed trait development for climate resilience.

TypeDirect peer
Description

Cibus develops non-transgenic gene-edited crop traits (e.g., disease and stress tolerance) using its Rapid Trait Development System. Closely comparable in non-GMO positioning and seed-company licensing model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alora

Agricultural Biotechnologyalora.world

Alora is an agricultural biotechnology company developing non-GMO multiplex gene-edited crop traits that redirect plant energy from stress defense to yield, licensing them B2B to seed companies with rice as the first validated crop.

What Alora does

Alora is an agricultural biotechnology company developing multiplex gene-edited crop traits that redirect plant energy from stress defense mechanisms to yield production. Its technology targets plant control systems rather than single genes, producing non-GMO edits that have demonstrated in rice a 1.5x yield increase under optimal greenhouse conditions, a 2-4x yield increase under extreme heat stress, and 100% survival under severe salinity, with 2025 UK open-field trials confirming greenhouse performance translates to real-world conditions. The company's primary operations are at Norwich Research Park in the United Kingdom, with the founding leadership team spanning genetics, plant biology, crop science, agronomy, and commercial ag-biotech experience (Adam Helms CEO, Luke Young CTO, Rory Hornby COO).

Alora operates as a B2B licensor of gene-edited crop traits to seed companies, which would integrate the traits into their commercial seed product lines for distribution to farmers. The company is pre-commercial and is currently focused on validating its traits across multiple crops and genetic backgrounds to support future seed-company commercial partnerships, with multi-location field trials planned for 2026. Marketing and lead generation run through a direct outreach model anchored by the company website's contact form (with categories for investors, seed companies, and general inquiries) and a LinkedIn presence.

The company has raised funding across multiple rounds beginning in 2019 with SOSV (IndieBio), followed by 2020 rounds with Next Humanity Ventures, a 2022 round of $1.4 million led with Mistletoe and Toyota Ventures, and a March 2026 round led by the Neglected Climate Opportunities Fund (Grantham Environmental Trust) with Toyota Ventures participation. Use of the most recent capital is to expand operations and advance ongoing trait development, consistent with a transition from research validation to commercial readiness.

Alora firmographics

Firmographics
Name
Alora
Legal name
Alora
Website
https://alora.world
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Alora is an agricultural biotechnology company developing non-GMO multiplex gene-edited crop traits that redirect plant energy from stress defense to yield, licensing them B2B to seed companies with rice as the first validated crop.
Ownership category
akta.pro rank

Alora industry classification

Industry
Product category
Agricultural Biotechnology
SIC
Agricultural Services (700)
akta.pro primary industry
Gene Editing Trait Development (CRISPR/TALEN/ZFN) (AFABALAB)
akta.pro secondary industries
Seed Trait Licensing & IP Management (Licensing, freedom-to-operate) (AFABALAJ), Biotechnology & Gene-Edited Trait Development (AFAGAIAG)

Keywords

  • Gene-edited crop traits
  • Agricultural biotechnology
  • Climate-resilient crops
  • Plant gene editing
  • Crop yield improvement

Where Alora is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Alora business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Trait Licensing to Seed Companies: ALORA licenses its gene-edited crop traits to seed companies. The company validates traits across multiple crops and genetic backgrounds to secure future commercial partnerships, generating revenue through trait licensing agreements.
  2. Seed Company Partnerships: The company is pursuing partnerships with seed companies to commercialize its gene-edited traits, indicating a B2B model where seed companies integrate ALORA's traits into their commercial seed products.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Alora product offering

Product offering

Core offering

Alora develops gene-edited crop traits using multiplex gene editing that targets plant control systems rather than single genes, redirecting plant energy from stress defense mechanisms to yield production. The company licenses these non-GMO traits to seed companies, with demonstrated performance in rice including 1.5x yield increase under optimal conditions, 2-4x yield under extreme heat stress, and 100% survival under severe salinity stress.

Product overview

Alora is an agricultural biotechnology company that develops a unified portfolio of gene-edited crop traits designed to improve how plants use energy, increasing yields under climate stress. The product suite includes Yield Enhancement Traits (up to 1.5× yield increase under optimal conditions), Heat Stress Yield Traits (2–4× yield under extreme heat), and Salinity Tolerance Traits (100% survival under severe salinity). All products are non-GMO and validated through controlled environment research and field trials, with primary operations at Norwich Research Park in the United Kingdom.

Differentiator

Problem solved

Functional benefit

Products and services

  • Gene-Edited Crop Traits A portfolio of non-GMO gene-edited crop traits that redirect plant energy from stress defense to yield, designed for licensing to seed companies for integration into commercial seed products. Validated in rice with potential for application across multiple crops.

Quantifiable outcome

  • Up to 1.5x yield increase under optimal conditions in rice
  • +3 more outcomes

Companies that use Alora

Customer profile

Segments2 records

Ideal customer profiles1 record

Alora technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Alora partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Alora competitors and assessment

Company assessment

Broad incumbents

  • Syngenta: Syngenta is one of the world's largest ag-input companies with extensive seed and trait operations across major crops. Broad incumbent competing in the same downstream seed-licensing ecosystem.
  • Corteva: Corteva is a global seed and crop protection company with a large proprietary trait pipeline including gene-edited traits. A broad incumbent that competes with ALORA for seed-company partnerships and licensing opportunities.
  • Bayer Crop Science: Bayer's Crop Science division operates the world's largest seed and trait platform, including its own gene-editing initiatives. Represents the dominant incumbent against which any seed-trait platform must compete.

Emerging players

  • Elo Life Systems: Elo Life Systems develops molecular-farming and crop-improvement traits, including yield and stress traits, using genomics and editing tools. Comparable as an emerging trait-licensing platform targeting food and agriculture customers.
  • Benson Hill: Benson Hill combines genomics, breeding, and AI to develop improved crop varieties for food and feed. Comparable in genomics-driven trait development and B2B seed/food value chain GTM.
  • Yield10 Bioscience: Yield10 is a small public ag-biotech developing gene-edited yield and stress traits in major row crops. Comparable in trait licensing model and focus on yield improvement, though at a more advanced public-stage profile.

Direct peers

  • Pairwise: Pairwise applies CRISPR-based gene editing to develop improved crop varieties, initially focused on corn, soybean, wheat, and produce. It competes directly with ALORA for seed-company licensing partnerships and uses the same non-GMO gene-editing regulatory positioning.
  • Tropic Biosciences: Tropic Biosciences develops gene-edited traits for tropical crops (banana, coffee, rice) using CRISPR. Direct overlap with ALORA on gene-edited rice traits and on the seed-company licensing GTM.
  • Inari Agriculture: Inari uses multiplex gene editing and AI to develop performance and sustainability traits in major row crops. It is the closest direct competitor to ALORA in system-level seed trait development for climate resilience.
  • Cibus: Cibus develops non-transgenic gene-edited crop traits (e.g., disease and stress tolerance) using its Rapid Trait Development System. Closely comparable in non-GMO positioning and seed-company licensing model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Alora social profiles

Digital presence

Alora financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alora leadership team

Management profile

Number of profiles

Profiles3 records

Alora funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alora M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alora

What does Alora do?

Alora develops gene-edited crop traits using multiplex gene editing that targets plant control systems rather than single genes, redirecting plant energy from stress defense mechanisms to yield production. The company licenses these non-GMO traits to seed companies, with demonstrated performance in rice including 1.5x yield increase under optimal conditions, 2-4x yield under extreme heat stress, and 100% survival under severe salinity stress.

Is Alora a public or private company?

Alora is a private company. It is classified as venture growth investor backed and is currently operating.

When was Alora founded?

Alora was founded in 2019. It employs 1 to 10 people.

Where is Alora based?

Alora is headquartered in San Francisco, United States, in the North America region.

How does Alora make money?

Two revenue lines are on record. Trait Licensing to Seed Companies are the primary driver. The others are seed Company Partnerships.

Who are Alora's main competitors?

Broad incumbents on record are Syngenta, Corteva and Bayer Crop Science. Emerging players are Elo Life Systems, Benson Hill and Yield10 Bioscience. Direct peers are Pairwise, Tropic Biosciences, Inari Agriculture and Cibus.

Does Alora have an API?

No public API is recorded for Alora.

What industry is Alora in?

Alora's product category is Agricultural Biotechnology. Its primary akta.pro industry code is AFABALAB, Gene Editing Trait Development (CRISPR/TALEN/ZFN), with a secondary code of AFABALAJ, Seed Trait Licensing & IP Management (Licensing, freedom-to-operate). Its SIC code is 700.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals